Global Transcatheter Structural Heart Device Market Research Report 2021

1 Transcatheter Structural Heart Device Market Overview

• 1.1 Product Overview and Scope of Transcatheter Structural Heart Device
• 1.2 Transcatheter Structural Heart Device Segment by Type
  • 1.2.1 Global Transcatheter Structural Heart Device Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Left Atrial Appendage Occluders
  • 1.2.3 Septal Defect Occluders
  • 1.2.4 Aortic Valve Replacement
  • 1.2.5 Mitral Valve Repair
  • 1.2.6 Mitral Valve Replacement (Experimental)
• 1.3 Transcatheter Structural Heart Device Segment by Application
  • 1.3.1 Transcatheter Structural Heart Device Sales Comparison by Application: (2021-2027)
  • 1.3.2 Congenital Heart Defects
  • 1.3.3 Aortic Stenosis
  • 1.3.4 Mitral Regurgitation
  • 1.3.5 Stroke
  • 1.3.6 Others
• 1.4 Global Transcatheter Structural Heart Device Market Size Estimates and Forecasts
  • 1.4.1 Global Transcatheter Structural Heart Device Revenue 2016-2027
  • 1.4.2 Global Transcatheter Structural Heart Device Sales 2016-2027
  • 1.4.3 Transcatheter Structural Heart Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Transcatheter Structural Heart Device Market Competition by Manufacturers

• 2.1 Global Transcatheter Structural Heart Device Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Transcatheter Structural Heart Device Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Transcatheter Structural Heart Device Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Transcatheter Structural Heart Device Manufacturing Sites, Area Served, Product Type
• 2.5 Transcatheter Structural Heart Device Market Competitive Situation and Trends
  • 2.5.1 Transcatheter Structural Heart Device Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Transcatheter Structural Heart Device Players Market Share by Revenue
  • 2.5.3 Global Transcatheter Structural Heart Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Transcatheter Structural Heart Device Retrospective Market Scenario by Region

• 3.1 Global Transcatheter Structural Heart Device Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Transcatheter Structural Heart Device Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Transcatheter Structural Heart Device Market Facts & Figures by Country
  • 3.3.1 North America Transcatheter Structural Heart Device Sales by Country
  • 3.3.2 North America Transcatheter Structural Heart Device Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Transcatheter Structural Heart Device Market Facts & Figures by Country
  • 3.4.1 Europe Transcatheter Structural Heart Device Sales by Country
  • 3.4.2 Europe Transcatheter Structural Heart Device Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Transcatheter Structural Heart Device Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Transcatheter Structural Heart Device Sales by Region
  • 3.5.2 Asia Pacific Transcatheter Structural Heart Device Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Transcatheter Structural Heart Device Market Facts & Figures by Country
  • 3.6.1 Latin America Transcatheter Structural Heart Device Sales by Country
  • 3.6.2 Latin America Transcatheter Structural Heart Device Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Transcatheter Structural Heart Device Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Transcatheter Structural Heart Device Sales by Country
  • 3.7.2 Middle East and Africa Transcatheter Structural Heart Device Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Transcatheter Structural Heart Device Historic Market Analysis by Type

• 4.1 Global Transcatheter Structural Heart Device Sales Market Share by Type (2016-2021)
• 4.2 Global Transcatheter Structural Heart Device Revenue Market Share by Type (2016-2021)
• 4.3 Global Transcatheter Structural Heart Device Price by Type (2016-2021)

5 Global Transcatheter Structural Heart Device Historic Market Analysis by Application

• 5.1 Global Transcatheter Structural Heart Device Sales Market Share by Application (2016-2021)
• 5.2 Global Transcatheter Structural Heart Device Revenue Market Share by Application (2016-2021)
• 5.3 Global Transcatheter Structural Heart Device Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Medtronic
  • 6.1.1 Medtronic Corporation Information
  • 6.1.2 Medtronic Description and Business Overview
  • 6.1.3 Medtronic Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Medtronic Product Portfolio
  • 6.1.5 Medtronic Recent Developments/Updates
• 6.2 Boston Scientific Corporation
  • 6.2.1 Boston Scientific Corporation Corporation Information
  • 6.2.2 Boston Scientific Corporation Description and Business Overview
  • 6.2.3 Boston Scientific Corporation Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Boston Scientific Corporation Product Portfolio
  • 6.2.5 Boston Scientific Corporation Recent Developments/Updates
• 6.3 Abbott
  • 6.3.1 Abbott Corporation Information
  • 6.3.2 Abbott Description and Business Overview
  • 6.3.3 Abbott Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Abbott Product Portfolio
  • 6.3.5 Abbott Recent Developments/Updates
• 6.4 Edwards Lifesciences Corporation
  • 6.4.1 Edwards Lifesciences Corporation Corporation Information
  • 6.4.2 Edwards Lifesciences Corporation Description and Business Overview
  • 6.4.3 Edwards Lifesciences Corporation Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Edwards Lifesciences Corporation Product Portfolio
  • 6.4.5 Edwards Lifesciences Corporation Recent Developments/Updates
• 6.5 Lifetech
  • 6.5.1 Lifetech Corporation Information
  • 6.5.2 Lifetech Description and Business Overview
  • 6.5.3 Lifetech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Lifetech Product Portfolio
  • 6.5.5 Lifetech Recent Developments/Updates
• 6.6 Braile Biomedica
  • 6.6.1 Braile Biomedica Corporation Information
  • 6.6.2 Braile Biomedica Description and Business Overview
  • 6.6.3 Braile Biomedica Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Braile Biomedica Product Portfolio
  • 6.6.5 Braile Biomedica Recent Developments/Updates
• 6.7 Micro Interventional Devices
  • 6.6.1 Micro Interventional Devices Corporation Information
  • 6.6.2 Micro Interventional Devices Description and Business Overview
  • 6.6.3 Micro Interventional Devices Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Micro Interventional Devices Product Portfolio
  • 6.7.5 Micro Interventional Devices Recent Developments/Updates
• 6.8 LivaNova PLC
  • 6.8.1 LivaNova PLC Corporation Information
  • 6.8.2 LivaNova PLC Description and Business Overview
  • 6.8.3 LivaNova PLC Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 LivaNova PLC Product Portfolio
  • 6.8.5 LivaNova PLC Recent Developments/Updates
• 6.9 Cryolife
  • 6.9.1 Cryolife Corporation Information
  • 6.9.2 Cryolife Description and Business Overview
  • 6.9.3 Cryolife Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Cryolife Product Portfolio
  • 6.9.5 Cryolife Recent Developments/Updates
• 6.10 Neovasc
  • 6.10.1 Neovasc Corporation Information
  • 6.10.2 Neovasc Description and Business Overview
  • 6.10.3 Neovasc Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Neovasc Product Portfolio
  • 6.10.5 Neovasc Recent Developments/Updates
• 6.11 4C Medical Technologies
  • 6.11.1 4C Medical Technologies Corporation Information
  • 6.11.2 4C Medical Technologies Transcatheter Structural Heart Device Description and Business Overview
  • 6.11.3 4C Medical Technologies Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 4C Medical Technologies Product Portfolio
  • 6.11.5 4C Medical Technologies Recent Developments/Updates
• 6.12 Highlife
  • 6.12.1 Highlife Corporation Information
  • 6.12.2 Highlife Transcatheter Structural Heart Device Description and Business Overview
  • 6.12.3 Highlife Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Highlife Product Portfolio
  • 6.12.5 Highlife Recent Developments/Updates
• 6.13 Lepu Medical
  • 6.13.1 Lepu Medical Corporation Information
  • 6.13.2 Lepu Medical Transcatheter Structural Heart Device Description and Business Overview
  • 6.13.3 Lepu Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Lepu Medical Product Portfolio
  • 6.13.5 Lepu Medical Recent Developments/Updates
• 6.14 Dinova Medtech
  • 6.14.1 Dinova Medtech Corporation Information
  • 6.14.2 Dinova Medtech Transcatheter Structural Heart Device Description and Business Overview
  • 6.14.3 Dinova Medtech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Dinova Medtech Product Portfolio
  • 6.14.5 Dinova Medtech Recent Developments/Updates
• 6.15 NewMed Medical
  • 6.15.1 NewMed Medical Corporation Information
  • 6.15.2 NewMed Medical Transcatheter Structural Heart Device Description and Business Overview
  • 6.15.3 NewMed Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 NewMed Medical Product Portfolio
  • 6.15.5 NewMed Medical Recent Developments/Updates
• 6.16 Venus Medtech
  • 6.16.1 Venus Medtech Corporation Information
  • 6.16.2 Venus Medtech Transcatheter Structural Heart Device Description and Business Overview
  • 6.16.3 Venus Medtech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Venus Medtech Product Portfolio
  • 6.16.5 Venus Medtech Recent Developments/Updates
• 6.17 Hanyu Medical
  • 6.17.1 Hanyu Medical Corporation Information
  • 6.17.2 Hanyu Medical Transcatheter Structural Heart Device Description and Business Overview
  • 6.17.3 Hanyu Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Hanyu Medical Product Portfolio
  • 6.17.5 Hanyu Medical Recent Developments/Updates

7 Transcatheter Structural Heart Device Manufacturing Cost Analysis

• 7.1 Transcatheter Structural Heart Device Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Transcatheter Structural Heart Device
• 7.4 Transcatheter Structural Heart Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Transcatheter Structural Heart Device Distributors List
• 8.3 Transcatheter Structural Heart Device Customers

9 Transcatheter Structural Heart Device Market Dynamics

• 9.1 Transcatheter Structural Heart Device Industry Trends
• 9.2 Transcatheter Structural Heart Device Growth Drivers
• 9.3 Transcatheter Structural Heart Device Market Challenges
• 9.4 Transcatheter Structural Heart Device Market Restraints

10 Global Market Forecast

• 10.1 Transcatheter Structural Heart Device Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Type (2022-2027)
• 10.2 Transcatheter Structural Heart Device Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Application (2022-2027)
• 10.3 Transcatheter Structural Heart Device Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List